Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-23

FDA Approved: VIZAMYL — Supplemental Application (GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare))

View source ↗

Summary

FDA approved a supplemental application for VIZAMYL (flutemetamol F-18) from GE Healthcare.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VIZAMYL (Flutemetamol F-18)

Snippet

SUPPL AP for VIZAMYL (FLUTEMETAMOL F-18)